ReviewClinical drug investigation2007

Regression or reduction in progression of atherosclerosis, and avoidance of coronary events, with lovastatin in patients with or at high risk of cardiovascular disease: a review.

Anna Frisinghelli et al.PubMed ↗Publisher ↗

No numbers read from the abstract.